Skip to content

Haemonetics

US · HAE #2165 by market cap Listed 1970
120.16 -0.21 -0.17%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 22 in the most recent period (2026/Q3).
  • Total institutional ownership fell 2.4 percentage points.

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
107.97% -2.44pp
Institutions
420 +22
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund83.54%
Hedge Fund13.99%
Public Company6.92%
Insurance Company1.32%
Individual/Insider1.30%
Private Company0.93%
Government Pension Fund0.92%
Sovereign Wealth Fund0.15%
Family Office/Trust0.12%

Top holders as of 2026-09-30

BlackRock 13.07% · 5.95M sh
Neuberger Berman Investment Advisers LLC 9.18% · 4.18M sh
Vanguard Portfolio Management, LLC 5.49% · 2.50M sh
AQR Capital Management 4.94% · 2.25M sh
Ariel Investments, LLC 4.53% · 2.06M sh
Vanguard Capital Management, LLC 4.49% · 2.05M sh
State Street Global Advisors 3.95% · 1.80M sh
T. Rowe Price Group, Inc. 3.82% · 1.74M sh
Citadel Advisors LLC 3.32% · 1.51M sh
Dimensional Fund Advisors 2.81% · 1.28M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 28 buys · 22 sells

NameRoleStake
Christopher Simon Chief Executive Officer 0.76%
Michelle Basil General Counsel 0.08%
Robert Abernathy Independent Director 0.05%
Mark Kroll Independent Director 0.05%
Laurie Miller Chief Human Resources Officer 0.05%
Charles Dockendorff Former Independent Director 0.05%
Ellen Zane Independent Chairperson 0.04%
James D'Arecca CFO, Executive VP & Financial Officer 0.04%
Claire Pomeroy Independent Director 0.04%
Michael Coyle Independent Director 0.03%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-10 Farris Maryanne Maunsell VP, Chief Accounting Officer & Principal Accounting Officer Open Market Disposition -414 $120.99
2026-11-10 Farris Maryanne Maunsell VP, Chief Accounting Officer & Principal Accounting Officer Derivative Exercise and Sale -2,146 $70.31–121.10
2026-10-29 Roy Galvin Executive Vice President Sale to Issuer -146 $119.65
2026-07-23 Robert Abernathy Independent Director Other Acquisition +2,538 --
2026-07-23 Michael Coyle Independent Director Other Acquisition +2,538 --
2026-07-23 Ellen Zane Independent Chairperson Other Acquisition +2,538 --
2026-07-23 Claire Pomeroy Independent Director Other Acquisition +2,538 --
2026-07-23 Mark Kroll Independent Director Other Acquisition +2,538 --
2026-07-23 Martin Madaus Director Other Acquisition +2,538 --
2026-07-23 Diane Bryant Independent Director Other Acquisition +2,538 --
2026-07-23 Lloyd Johnson Independent Director Other Acquisition +2,538 --
2026-06-04 Laurie Miller Chief Human Resources Officer Sale to Issuer -313 $71.28
2026-06-04 Farris Maryanne Maunsell VP, Chief Accounting Officer & Principal Accounting Officer Sale to Issuer -259 $71.28
2026-05-14 Michelle Basil General Counsel Sale to Issuer -2,913 $56.29
2026-05-14 Michelle Basil General Counsel Other Acquisition +28,424 --
2026-05-14 Christopher Simon Chief Executive Officer Sale to Issuer -9,681 $56.29
2026-05-14 Christopher Simon Chief Executive Officer Other Acquisition +78,344 --
2026-05-14 James D'Arecca CFO, Executive VP & Financial Officer Sale to Issuer -2,505 $56.29
2026-05-14 James D'Arecca CFO, Executive VP & Financial Officer Other Acquisition +29,312 --
2026-05-14 Laurie Miller Chief Human Resources Officer Sale to Issuer -948 $56.29

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Haemonetics discussion 0 comments

Add a comment